Similar Articles
1181 Identification of biomarkers for hepatocellular carcinoma by semiquantitative immunocytochemistry
1182 Laparoscopic liver resections for hepatocellular carcinoma: Current role and limitations
1183 MT1M and MT1G promoter methylation as biomarkers for hepatocellular carcinoma
1184 Hepatocellular carcinoma review: Current treatment, and evidence-based medicine
1185 Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma
1186 Staging systems of hepatocellular carcinoma: A review of literature
1187 Chemotherapy for advanced hepatocellular carcinoma in the sorafenib age
1188 Anatomic resection of liver segments 6-8 for hepatocellular carcinoma
1189 New approaches for precise response evaluation in hepatocellular carcinoma
1190 Transarterial chemoembolization and bland embolization for hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA